Skip to content
London ACE Media

The Zimbabwean Government Rejects ‘Unbalanced’ American Health Aid Deal Over Information Apprehensions

Health aid image
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a major American health deal valued at $367m (272 million pounds) spanning five years due to the United States' demand for confidential biological samples.

The decision became public following a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government spokesman has since explained that the US was demanding access to health data for research and commercial purposes but was unwilling to share the resulting advantages from future treatments.

"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged further negotiations to secure a deal agreeable to all parties so the country's critical HIV treatment initiative can be sustained.

Broader Background

Zimbabwe's decision follows a similar situation in Kenya, where a court suspended a related health funding agreement following concerns were raised about the safety of citizens' medical information.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

USAID had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.

According to statements, 16 nations in Africa have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Deal

This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment through US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," Mangwana explained.

"Put simply, our nation would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our citizens if a future pandemic emerge."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining structures previously established through the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.

"This system is intended to ensure that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.

"We are open to ongoing discussions with our US partners on how subsequent collaboration could be arranged in a manner that respects the independence and dignity of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations must proceed since a large portion of the nation's Aids initiatives depended on foreign aid.

"Where technical issues arise, including those relating to information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it added.

The halted deal underscores the complex challenges between receiving vital international aid and safeguarding national sovereignty in an ever more data-driven world.

RN
The writer

Robert Norman

Eleanor Hartwell is a multi-award-winning media strategist and storyteller with over 15 years of experience in digital content creation.

London ACE Media

Type to search articles.